# Urologic Oncology Seminars and Original Investigations

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/urologic-oncology-seminars-and-original-investigations/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1078-1439 |
| ISSNs | 1078-1439,1873-2496 |
| OpenAlex ID | https://openalex.org/S4802544 |
| Publisher | Elsevier BV |

## Journal papers

Showing 12 of 15.

- [Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer](https://scholariq.org/papers/patterns-of-use-of-systemic-chemotherapy-for-medicare-beneficiaries-with/)
- [The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial](https://scholariq.org/papers/the-personal-patient-profile-prostate-decision-support-for-men-with-localized/)
- [Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non–muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis](https://scholariq.org/papers/prognostic-role-of-pretreatment-neutrophil-to-lymphocyte-ratio-nlr-in-patients/)
- [Heterogeneity in renal cell carcinoma](https://scholariq.org/papers/heterogeneity-in-renal-cell-carcinoma/)
- [Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments](https://scholariq.org/papers/frailty-as-a-predictor-of-complications-after-radical-cystectomy-a-prospective/)
- [Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma](https://scholariq.org/papers/pathologic-response-and-surgical-outcomes-in-patients-undergoing-nephrectomy/)
- [Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer](https://scholariq.org/papers/long-term-follow-up-of-sequential-intravesical-gemcitabine-and-docetaxel-salvage/)
- [Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting](https://scholariq.org/papers/real-world-outcomes-in-patients-with-metastatic-castration-resistant-prostate/)
- [Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging](https://scholariq.org/papers/diagnostic-performance-of-prospectively-assigned-clear-cell-likelihood-scores/)
- [Assessments of frailty in bladder cancer](https://scholariq.org/papers/assessments-of-frailty-in-bladder-cancer/)
- [Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy](https://scholariq.org/papers/frailty-syndrome-is-associated-with-changes-in-peripheral-inflammatory-markers/)
- [MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway](https://scholariq.org/papers/mk2206-potentiates-cisplatin-induced-cytotoxicity-and-apoptosis-through-an/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.